All In Biotech

Drug Trial Radar · NCT00002812

Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia

Treatment of Patients With Acute Lymphoblastic Leukemia With Unfavorable Features: A Phase III Group-wide Study

Last checked: Nov 19, 2026Latest source record: Aug 26, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 2,078 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,078

Actual

Start

Sep 1996

Primary completion

Mar 2006

Sponsor

Lead sponsor
Children's Oncology GroupResearch network
Sponsor type
Research network
Collaborators
National Cancer Institute (NCI)
First posted
Nov 24, 2003

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 1 year, up to 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug and giving the drugs in different combinations may kill more cancer cells. PURPOSE: Randomized phase III trial to compare the effectiveness of standard combination chemotherapy treatment with more intensive combination chemotherapy in treating children with acute lymphocytic leukemia.

Conditions

  • Leukemia

Interventions

  • asparaginaseDrug

    Given IV

  • cyclophosphamideDrug

    Given IV

  • cytarabineDrug

    Given IV

  • daunorubicin hydrochlorideDrug

    Given IV

  • dexamethasoneDrug

    Given IV

  • doxorubicin hydrochlorideDrug

    Given IV

  • idarubicinDrug

    Given IV

  • mercaptopurineDrug

    Given IV

  • methotrexateDrug

    Given PO

  • pegaspargaseDrug

    Given IV

  • prednisoneDrug

    Given PO

  • thioguanineDrug

    Given IV

  • vincristine sulfateDrug

    Given IV

  • radiation therapyRadiation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Event Free SurvivalTime frame: from the time of randomization where the life table events will consist of the first occurrence of the following events: failure to achieve remission, leukemic relapse at any site, death, or occurrence of a second malignancy.

Locations

35 sites in 3 countries. Site status is shown where the registry gives one.

  • Long Beach Memorial Medical Center

    Long Beach, California

  • Children's Hospital Los Angeles

    Los Angeles, California

  • Jonsson Comprehensive Cancer Center, UCLA

    Los Angeles, California

  • Children's Hospital of Orange County

    Orange, California

  • UCSF Cancer Center and Cancer Research Institute

    San Francisco, California

  • Children's Hospital of Denver

    Denver, Colorado

  • Children's National Medical Center

    Washington D.C., District of Columbia

  • University of Chicago Cancer Research Center

    Chicago, Illinois

  • Indiana University Cancer Center

    Indianapolis, Indiana

  • Holden Comprehensive Cancer Center at The University of Iowa

    Iowa City, Iowa

  • University of Michigan Comprehensive Cancer Center

    Ann Arbor, Michigan

  • University of Minnesota Cancer Center

    Minneapolis, Minnesota

  • Mayo Clinic Cancer Center

    Rochester, Minnesota

  • Children's Mercy Hospital

    Kansas City, Missouri

  • University of Nebraska Medical Center

    Omaha, Nebraska

  • Saint Peter's University Hospital

    New Brunswick, New Jersey

  • NYU School of Medicine's Kaplan Comprehensive Cancer Center

    New York, New York

  • Memorial Sloan-Kettering Cancer Center

    New York, New York

  • Mount Sinai School of Medicine

    New York, New York

  • Herbert Irving Comprehensive Cancer Center

    New York, New York

  • Lineberger Comprehensive Cancer Center, UNC

    Chapel Hill, North Carolina

  • Children's Hospital Medical Center - Cincinnati

    Cincinnati, Ohio

  • Ireland Cancer Center

    Cleveland, Ohio

  • Children's Hospital of Columbus

    Columbus, Ohio

  • Doernbecher Children's Hospital

    Portland, Oregon

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania

  • Children's Hospital of Pittsburgh

    Pittsburgh, Pennsylvania

  • Vanderbilt-Ingram Cancer Center

    Nashville, Tennessee

  • University of Texas - MD Anderson Cancer Center

    Houston, Texas

  • Children's Hospital and Regional Medical Center - Seattle

    Seattle, Washington

  • Fred Hutchinson Cancer Research Center

    Seattle, Washington

  • University of Wisconsin Comprehensive Cancer Center

    Madison, Wisconsin

  • Princess Margaret Hospital for Children

    Perth, Western Australia, Australia

  • British Columbia Children's Hospital

    Vancouver, British Columbia, Canada

  • IWK Health Centre

    Halifax, Nova Scotia, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.